Swisse is harnessing the power of a little-known plant called Andrographis paniculata to relieve symptoms of the common cold and provide immune support.
Nestlé Japan has announced plans to branch out from the food and beverage business into healthcare, with personalised nutrition and aged care a prominent feature of this shift.
Innovation Network Corporation of Japan (INCJ) and Mitsubishi Corporation (MC) have invested 1.7 billion yen in Spirulina manufacturer Tavelmout Corporation.
Asia Pacific’s rapidly ageing population will drive significant opportunities for the region’s food and nutrition industry, according to keynote speakers on day one of the inaugural event in Singapore.
Australian supplement firm Bod Australia will see George Livery — Swisse's former strategy and corporate director — join its ranks as executive chairman in September this year to drive the firm’s growth strategy in supplements and medical cannabis...
Infant formula firm Bubs Australia has entered a binding manufacturing agreement with a CNCA-licensed production facility as part of its efforts to achieve CFDA (China Food and Drug Administration) registration, while also inking a deal with Alibaba to...
Machine-based learning could be as effective as the human ear when it comes to detecting infant crying or fussing, opening up possibilities for potential clinical applications such as detecting colic.
Bubs Australia has signed a supply agreement with New Times Asia, a China-based supply chain and service provider, which will lead to a significant increase in its distribution in the country.
Customer service, environmental consciousness and constant innovation are crucial to longevity in the health and nutrition industry, according to Blackmores managing director Dave Fenlon.
Indian firm Zydus Wellness is seeking to tap to into the country's food fortification drive by launching an egg-free mayonnaise called Nutralite, fortified with vitamins A, D and E.
Morinaga Milk's financial results for the last year saw a slight dip overall, with net sales falling 0.1% (¥530m) year-on-year to ¥592,087m, but the firm is targeting sales success with its higher-value functional products.
Bega Bionutrients, the health and ingredient arm of Australian firm Bega Cheese, has launched a novel form of microencapsulated infant formula ingredient lactoferrin – Inferrin.
A supplement containing a proprietary hop flower extract from New Zealand is entering the US market, positioned for weight management through appetite control.
